RxDoctor Payments Data

Amanda Sullivan

Nurse Practitioner · Flowood, MSNPI 1386010379

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,453 and has fallen 56.1% since, to $637 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,202in general payments, 2019–2025

Across 316 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Exeltis, USA Inc.$955
  • Astellas Pharma US Inc$424
  • Pfizer$326
  • Organon$320
  • Mayne Pharma Commercial LLC$306
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$5,10898%
  • Education$942%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,202 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$11,296
Medicare patients
81
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol31$863
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$185
Zolpidem Tartrate30$171
Fluconazole17$72
Citalopram HbrCitalopram Hydrobromide22$68

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →